> MEDIA   Overview   Press Releases   Media Stories   Download Center   Video Gallery   Photo Gallery   Media Contacts

Press Releases 2017 2018 2019   2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005       December 2013 18 Dec  Biocon and Quark Pharmaceuticals  Collaborate to Develop Novel siRNA based  Therapeutics   November 2013 26 Nov  Biocon & Mylan Receive Indian Regulatory  Approval for Trastuzumab for Treating  Breast Cancer 11 Nov  Biocon Unveils Biocon Academy - A Center  of Excellence for Advanced Learning in  Applied Biosciences   October 2013 24 Oct  Sustained Momentum in Biopharma &  Research Services delivers 19% growth for  Biocon   September 2013 13 Sep  Biocon Partners with CytoSorbents to  Market CytoSorb® - A 'First-in-Class'  Therapy for Sepsis Management   August 2013 10 Aug  Biocon Launches ALZUMAb™ - a  'First in Class' Novel Biologic Treatment for  Psoriasis Patients in India   July 2013 25 Jul  Biocon Delivers a Healthy Growth of 22%  driven by strong traction in Biopharma   April 2013 25 Apr  Biocon delivers a strong performance of  18% Revenue Growth in FY13 driven by an  evolving Product Portfolio & Research  Services   February 2013 24 Feb  Biocon Enhances Partnership with Mylan  through Strategic Collaboration for  Insulin Products   January 2013 24 Jan  Kiran Mazumdar-Shaw joins U.S.  Pharmacopeial Convention (USP)  Board of Trustees 24 Jan  Biocon's Nine Months Revenue Continues  to Deliver Steady Growth in FY13 08 Jan  Biocon Receives Marketing Authorization  for its Novel Biologic Itolizumab for  Psoriasis

Biocon Businesses Recommended sites Biocon on     Home About Us Investor Relations Media Relations Careers Site Map Contact Us Our Growth Accelerators Fact Sheet Branded Formulations Biopharmaceuticals Research Services Active Discovery Program ABLE Karnataka Vision Group on BT Syngene International Biocon Academy                   Report adverse event/side effects and product complaints               * Disclaimer            © 2018, Biocon. All Rights Reserved